Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Pathol ; 157(5): 1439-45, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11073803

RESUMEN

Reactive nitrogen species may play a mechanistic role in neurodegenerative diseases by posttranslationally altering normal brain proteins. In support of this hypothesis, we demonstrate that an anti-3-nitrotyrosine polyclonal antibody stains all of the major hallmark lesions of synucleinopathies including Lewy bodies, Lewy neurites and neuraxonal spheroids in dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and neurodegeneration with brain iron accumulation type 1, as well as glial and neuronal cytoplasmic inclusions in multiple system atrophy. This antibody predominantly recognized nitrated alpha-synuclein when compared to other in vitro nitrated constituents of these pathological lesions, such as neurofilament subunits and microtubules. Collectively, these findings imply that alpha-synuclein is nitrated in pathological lesions. The widespread presence of nitrated alpha-synuclein in diverse intracellular inclusions suggests that oxidation/nitration is involved in the onset and/or progression of neurodegenerative diseases.


Asunto(s)
Encefalopatías/metabolismo , Cuerpos de Inclusión/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Enfermedades Neurodegenerativas/metabolismo , Nitratos/metabolismo , Tirosina/análogos & derivados , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos/inmunología , Western Blotting , Encefalopatías/patología , Femenino , Humanos , Inmunohistoquímica , Cuerpos de Lewy/metabolismo , Masculino , Persona de Mediana Edad , Enfermedades Neurodegenerativas/patología , Neuroglía/metabolismo , Sinucleínas , Distribución Tisular , Tirosina/inmunología , Tirosina/metabolismo , alfa-Sinucleína
2.
J Neuropathol Exp Neurol ; 59(9): 830-41, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11005264

RESUMEN

Although alpha-synuclein (alpha-syn) has been implicated as a major component of the abnormal filaments that form glial cytoplasmic inclusions (GCIs) in multiple system atrophy (MSA), it is uncertain if GCIs are homogenous and contain full-length alpha-syn. Since this has implications for hypotheses about the pathogenesis of GCIs, we used a novel panel of antibodies to defined regions throughout alpha-syn in immunohistochemical epitope mapping studies of GCIs in MSA brains. Although the immunostaining profile of GCIs with these antibodies was similar for all MSA brains, there were significant differences in the immunoreactivity of the alpha-syn epitopes detected in GCIs. Notably, carboxy-terminal alpha-syn epitopes were immunodominant in GCIs, but the entire panel of antibodies immunostained cortical Lewy bodies (LBs) in dementia with LBs brain with similar intensity. While the distribution of alpha-syn labeled GCIs paralleled that previously reported using silver stains, antibodies to carboxy-terminal alpha-syn epitopes revealed a previously undescribed burden of GCIs in the MSA hippocampal formation. Finally, Western blots demonstrated detergent insoluble monomeric and high-molecular weight alpha-syn species in GCI rich MSA cerebellar white matter. Collectively, these data indicate that alpha-syn is a prominent component of GCIs in MSA, and that GCIs and LBs may result from cell type specific conformational or post-translational permutations in alpha-syn.


Asunto(s)
Encéfalo/patología , Atrofia de Múltiples Sistemas/patología , Proteínas del Tejido Nervioso/análisis , Anciano , Anciano de 80 o más Años , Anticuerpos , Anticuerpos Monoclonales , Ganglios Basales/patología , Cerebelo/patología , Femenino , Hipocampo/patología , Humanos , Inmunohistoquímica , Masculino , Bulbo Raquídeo/patología , Mesencéfalo/patología , Persona de Mediana Edad , Puente/patología , Sinucleínas , alfa-Sinucleína
3.
Neurology ; 54(10): 1916-21, 2000 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-10822429

RESUMEN

BACKGROUND: Dementia is a frequent complication of idiopathic parkinsonism or PD, usually occurring later in the protracted course of the illness. The primary site of neuropathologic change in PD is the substantia nigra, but the neuropathologic and molecular basis of dementia in PD is less clear. Although Alzheimer's pathology has been a frequent finding, recent advances in immunostaining of alpha-synuclein have suggested the possible importance of cortical Lewy bodies (CLBs) in the brains of demented patients with PD. METHODS: The brains of 22 demented and 20 nondemented patients with a clinical and neuropathologic diagnosis of PD were evaluated with standard neuropathologic techniques. In addition, CLBs and dystrophic neurites were identified immunohistochemically with antibodies specific for alpha-synuclein and ubiquitin; plaques and tangles were identified by staining with thioflavine S. Associations between dementia status and pathologic markers were tested with logistic regression. RESULTS: CLBs positive for alpha-synuclein are highly sensitive (91%) and specific (90%) neuropathologic markers of dementia in PD and slightly more sensitive than ubiquitin-positive CLBs. They are better indicators of dementia than neurofibrillary tangles, amyloid plaques, or dystrophic neurites. CONCLUSION: CLBs detected by alpha-synuclein antibodies in patients with PD are a more sensitive and specific correlate of dementia than the presence of Alzheimer's pathology, which was present in a minority of the cases in this series.


Asunto(s)
Corteza Cerebral/patología , Demencia/patología , Cuerpos de Lewy/patología , Proteínas del Tejido Nervioso/análisis , Enfermedad de Parkinson/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/análisis , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Sinucleínas , alfa-Sinucleína
4.
Radiology ; 212(1): 143-50, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10405733

RESUMEN

PURPOSE: To evaluate the temporal evolution and appearance of a radiosurgical lesion at magnetic resonance (MR) imaging and the clinical response in patients undergoing stereotactic radiosurgical pallidotomy or thalamotomy with the gamma knife. MATERIALS AND METHODS: Seventeen patients with medically refractory movement disorders underwent stereotactic radiosurgical pallidotomy (n = 2) or thalamotomy (n = 15). A single dose of 120-140 Gy was administered to a target in the globus pallidus interna or ventralis intermedius thalamic nucleus. Postprocedure gadolinium-enhanced MR imaging and clinical assessment were performed at 1 month and 3 months. RESULTS: At 3 months, the radiosurgical lesion most commonly (n = 11) appeared as a ring-enhancing focus 5 mm or less in diameter surrounded by vasogenic edema that extended less than 7 mm in radius beyond the target. Five patients had ring-enhancing lesions 7 mm or more in diameter; four of these developed symptomatic perilesional edema at 3 (n = 2) or 8 (n = 2) months after the procedure. Onset of therapeutic effect began approximately 4 weeks after treatment. In the 15 patients with tremor, there was a mean decline of 2.1 on the Tremor Rating Scale. CONCLUSION: Findings in this pilot study suggest that radiosurgical thalamotomy is a promising treatment for medically refractory tremor. Three-month follow-up MR studies show a ring-enhancing lesion surrounded by a variable amount of vasogenic edema. Visualization of the radiosurgical lesion and the clinical response are delayed compared to that with radio-frequency procedures.


Asunto(s)
Globo Pálido/cirugía , Imagen por Resonancia Magnética , Examen Neurológico , Enfermedad de Parkinson/cirugía , Complicaciones Posoperatorias/diagnóstico , Radiocirugia , Técnicas Estereotáxicas , Núcleos Talámicos/cirugía , Temblor/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Edema Encefálico/diagnóstico , Mapeo Encefálico , Femenino , Globo Pálido/patología , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/diagnóstico , Núcleos Talámicos/patología , Resultado del Tratamiento , Temblor/diagnóstico
5.
Neurology ; 44(2): 266-8, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8309571

RESUMEN

Decreased olfactory function commonly occurs in idiopathic Parkinson's disease (PD), regardless of stage, treatment, or duration of disease. In the present study, we sought to determine whether different subtypes of PD, categorized according to well-defined clinical criteria, evidence different degrees of olfactory dysfunction. Significantly different scores on the University of Pennsylvania Smell Identification Test (UPSIT) were present between patients with benign PD and malignant PD (respective means [SD] = 22.51 [8.50] and 17.38 [6.29]) and between tremor-predominant PD and postural instability-gait disorder (PIGD)-predominant PD (23.43 [8.18] versus 17.35 [6.00]). No statistically significant differences in UPSIT scores were observed between young-onset and older-onset PD patients. Women outperformed men in most subtypes examined.


Asunto(s)
Enfermedad de Parkinson/fisiopatología , Olfato/fisiología , Adulto , Factores de Edad , Edad de Inicio , Anciano , Análisis de Varianza , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/clasificación , Factores Sexuales
6.
J Cogn Neurosci ; 5(4): 480-98, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-23964920

RESUMEN

Abstract Sentence comprehension is a complex process involving at least a grammatical processor and a procedural component that supports language computations. One type of cerebral architecture that may underlie sentence processing is a network of distributed brain regions. We report two experiments designed to evaluate the cognitive and physiological substrate of sentence processing diaculties in nondemented patients with Parkinson's disease (PD). In the first experiment, patients answered simple questions about sentences that varied in their computational demands. Group and individual patient analyses indicated that PD patients are significantly compromised on this task, and that their difficulties become more prominent as the computational demands of the sentences increase. We manipulated the set of sentences to stress performance aspects of sentence processing. PD patients were compromised in their ability to detect errors in the presence and nature of a sentence's grammatical morphemes, suggesting a deficit in selective attention, but their ability to answer questions about a sentence was not afFected by short-term memory factors. In the second experiment, positron emission tomography was used to correlate this pattern of sentence comprehension impairment with regional cerebral glucose metabolism (rCMRgl) obtained at rest in a representative subset of these PD patients. Grammatical comprehension and attention in sentence processing correlated significantly with mesial frontal rCMRgl. Regression analyses confirmed the central role of left mesial frontal cortex, and identified a subsidiary role for left caudate in overall sentence comprehension, for left dorsolateral frontal cortex in grammatical processing, and for bilateral dorsolateral frontal cortex in attending to the presence of grammatical features. We conclude that compromised mesial frontal functioning underlies in part the sentence processing deficit of these patients, and these data illustrate one method for mapping portions of a sentence processing mechanism onto a distributed cerebral architecture.

7.
Brain Lang ; 42(4): 347-84, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-1611464

RESUMEN

Sentence comprehension is a complex process involving at least attentional, memory, grammatical, and semantic components. We report three experiments designed to evaluate the impairments underlying sentence comprehension difficulties in nondemented patients with Parkinson's disease (PD). In the first experiment, we asked patients to answer simple questions about sentences which varied in terms of grammatical complexity and semantic constraint. We found that PD patients are significantly compromised in their ability to perform this task. Their difficulties became more prominent as grammatical complexity increased, but they were significantly assisted by semantic constraints that limited possible interpretations of a sentence. Analyses of individual patient profiles revealed heterogeneous performance across the group of PD patients and somewhat inconsistent performance for patients across testing sessions. In the second experiment, we tested the possibility that patients' heterogeneous performance on the sentence comprehension task is due to an impairment in memory or attention, cognitive domains known to be compromised in some PD patients. Although PD patients and control subjects differed on one memory measure, there were no significant correlations between attention and memory performance and the results of the sentence comprehension task. In the final experiment, we manipulated the sentences used in the first experiment in a fashion that stressed the need for memory and attention in a sentence. The results indicated that PD patients are significantly compromised in their ability to attend to certain critical grammatical features of a sentence. A regression analysis identified specific grammatical, semantic, and attentional mechanisms as significant contributors to PD patients' overall sentence comprehension, accounting for over 97% of the variance in their performance. We conclude that there are multiple sources of cognitive difficulty underlying PD patients' sentence comprehension impairment.


Asunto(s)
Atención , Formación de Concepto , Recuerdo Mental , Enfermedad de Parkinson/psicología , Semántica , Anciano , Humanos , Persona de Mediana Edad , Examen Neurológico , Pruebas Neuropsicológicas , Enfermedad de Parkinson/diagnóstico
8.
J Neurol Neurosurg Psychiatry ; 55(2): 138-42, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1538221

RESUMEN

Decreased olfactory function is among the first signs of idiopathic Parkinson's disease (PD). Whether such dysfunction is present to the same degree on both sides of the nose, however, is unknown. Furthermore, whether the deficit results from or is influenced by anti-Parkinsonian medications has not been definitely established. Odour identification ability was evaluated on the left and right sides of the nose in 20 early-stage untreated PD patients, 20 early-stage treated PD patients, and 20 controls. In all cases, the PD related olfactory dysfunction was bilateral and no difference was observed between the test scores of patients taking or not taking drugs for PD. Although asymmetries of unsystematic direction were present in the test scores of some PD patients, similar asymmetries were observed in the controls and the asymmetries were not related to the side of the major motor dysfunction. As in earlier work, no relation was present between the olfactory test scores and the degree of tremor, rigidity, bradykinesia, or gait disturbance at the time of testing. These findings indicate that the olfactory dysfunction of early stage PD is robust, typically of the same general magnitude on both sides of the nose, and uninfluenced by anti-Parkinsonian medications.


Asunto(s)
Antiparkinsonianos/uso terapéutico , Lateralidad Funcional/fisiología , Enfermedad de Parkinson/fisiopatología , Olfato , Factores de Edad , Femenino , Humanos , Masculino , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/etiología , Enfermedades del Sistema Nervioso/fisiopatología , Examen Neurológico , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/tratamiento farmacológico , Factores Sexuales
9.
Neurology ; 41(10): 1620-6, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1922805

RESUMEN

We evaluated the ability of nondemented patients with idiopathic Parkinson's disease (PD) to interpret various aspects of sentences and to perform learned limb and oral gestures. The patients were significantly compromised in their ability to answer simple questions about sentences such as "The eagle chased the hawk that was fast. Which bird was chased?" A discriminant analysis revealed that up to 73% of PD patients differ from control subjects in their ability to perform this task. Patients with PD were also significantly compromised in their gestural performance, and a discriminant analysis indicated that a praxis deficit may be evident in up to 64% of patients. We conclude that language and gestural processing impairments are frequent in patients with PD.


Asunto(s)
Pruebas del Lenguaje , Enfermedad de Parkinson/psicología , Desempeño Psicomotor , Anciano , Humanos , Persona de Mediana Edad
10.
Arch Neurol ; 48(9): 903-7, 1991 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1953412

RESUMEN

While the cause of Parkinson's disease (PD) remains unknown, recent evidence suggests that certain external factors, ie, environmental agents, may act as neurotoxins, initiating the chain of oxidative reactions that ultimately destroy neurons in the substantia nigra. Young-onset PD might result from greater exposure to a putative neurotoxin. This hypothesis has rekindled interest in the epidemiology of PD. We therefore conducted a detailed analysis of various environmental exposures and early life experiences in 80 patients with old-onset PD (at an age older than 60 years), 69 young-onset patients (younger than 40 years), and 149 age- and sex-matched control subjects. Contrary to previous reports, we were unable to implicate well water or exposure to herbicides, pesticides, or industrial toxins as significant PD risk factors. A residential history of rural living was reported by more patient cases than control subjects and was marginally significant. On the other hand, at least one episode of head trauma "severe enough to cause vertigo, dizziness, blurred or double vision, seizures or convulsions, transient memory loss, personality changes, or paralysis" occurred significantly more often prior to disease onset in patients with both young-onset and old-onset PD than in control subjects (odds ratio = 2.7). When adjusted for head trauma and rural living, smoking was inversely associated with PD, as has been previously reported (odds ratio = 0.5). There were no significant differences in early life experiences or environmental exposures between young-onset and old-onset patients. We suggest that the risk of developing PD is influenced by a variety of factors.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Enfermedad de Parkinson/etiología , Adulto , Factores de Edad , Anciano , Lesiones Encefálicas/complicaciones , Estudios de Casos y Controles , Exposición a Riesgos Ambientales , Femenino , Humanos , Insecticidas/efectos adversos , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/epidemiología , Plaguicidas/efectos adversos , Factores de Riesgo , Población Rural , Fumar/efectos adversos
11.
J Neurol Neurosurg Psychiatry ; 50(9): 1228-9, 1987 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-3668573

RESUMEN

A case of transient post-varicella lingual-mandibular dystonia is presented. This case was compared with the eight previously reported instances of involuntary movement disorders which rarely follow varicella infection.


Asunto(s)
Varicela/complicaciones , Distonía/etiología , Adolescente , Movimientos Oculares , Femenino , Humanos , Recurrencia , Trastornos del Habla/etiología
12.
Bull Clin Neurosci ; 51: 52-6, 1986.
Artículo en Inglés | MEDLINE | ID: mdl-3455244

RESUMEN

We studied the effect of adding low-dose bromocriptine to levodopa/carbidopa (Sinemet) in 26 patients suffering from progressive Parkinson's disease with loss of levodopa effectiveness or levodopa-induced fluctuations. Despite the high incidence of drug intolerance and low response rates, a significant proportion of patients with the wearing-off effect and dystonia improved. Low-dose, slow-increase bromocriptine is warranted as adjunctive therapy in these patient subgroups.


Asunto(s)
Bromocriptina/uso terapéutico , Levodopa/efectos adversos , Enfermedad de Parkinson/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Relación Dosis-Respuesta a Droga , Tolerancia a Medicamentos , Humanos , Levodopa/uso terapéutico , Persona de Mediana Edad
15.
Neurology ; 32(12): 1335-46, 1982 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6128697

RESUMEN

It is not widely recognized that antipsychotic drugs can cause late-onset and persistent dystonia. This dystonia, which we call tardive dystonia, is to be distinguished from acute dystonic reactions, which are transient, and from classic tardive dyskinesia, which is a choreic disorder that predominantly affects the oral region. We present 42 patients with tardive dystonia. The age of onset of dystonia was 13 to 60 years. Symptoms began after 3 days to 11 years of antipsychotic therapy. Younger patients tended to have more generalized dystonia. In a few patients, spontaneous remission occurred, but dystonia persisted for years in most. Therapy was rarely a complete success. The most frequently helpful medications were tetrabenazine (68% of patients improved) and anticholinergics (39% improved).


Asunto(s)
Antipsicóticos/efectos adversos , Distonía/inducido químicamente , Adolescente , Adulto , Niño , Preescolar , Diagnóstico Diferencial , Distonía/diagnóstico , Distonía/fisiopatología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA